summit study tirzepatide hfpef trial In pts wiht HFpEF and obesity, tirzepatide (Mounjaro®) significantly reduces HF hospitalization, diuretic intensification, or CV death by 38% vs placebo in trial https://t.co/8ZHm4gySiL Lilly's Tirzepatide Reduces Heart Failure

The Finkelstein test, where you make a fist over your thumb and bend your wrist toward your pinky, typically reproduces the pain

Topamax (topiramate): label change risk for development of cleft lip and/or cleft palate in newborns

Over time, these small shifts in appetite and glycemia can produce modest reductions in body weight

Wegovy (semaglutide) is a once-weekly injectable prescription medication thats FDA-approved for weight loss and cardiovascular risk reduction in people with obesity and overweight

Anti-inflammatory characteristics found in carotenoids make them useful for controlling the inflammatory response

This new terminology more accurately reflectsthe strong association between the disease and metabolic abnormalities